Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
32.39
-0.60 (-1.82%)
At close: Apr 28, 2026, 4:00 PM EDT
32.74
+0.35 (1.08%)
Pre-market: Apr 29, 2026, 7:53 AM EDT
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $3.75 billion as of April 29, 2026. Its market cap has increased by 50.51% in one year.
Market Cap
3.75B
Enterprise Value
3.05B
1-Year Change
50.51%
Ranking
Category
Stock Price
$32.39
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $3.75B, an increase of 4,743.62%. That is a compound annual growth rate of 42.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3.74B | -5.88% |
| Dec 31, 2025 | 3.98B | -11.32% |
| Dec 31, 2024 | 4.48B | 140.89% |
| Dec 29, 2023 | 1.86B | 158.22% |
| Dec 30, 2022 | 720.90M | 100.31% |
| Dec 31, 2021 | 359.90M | -12.37% |
| Dec 31, 2020 | 410.70M | -29.14% |
| Dec 31, 2019 | 579.60M | 6.02% |
| Dec 31, 2018 | 546.70M | 372.52% |
| Dec 29, 2017 | 115.70M | 382.08% |
| Dec 30, 2016 | 24.00M | -27.27% |
| Dec 31, 2015 | 33.00M | -57.42% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Legend Biotech | 4.36B |
| Crinetics Pharmaceuticals | 3.99B |
| ACADIA Pharmaceuticals | 3.87B |
| Veradermics | 3.85B |
| Travere Therapeutics | 3.78B |
| Oruka Therapeutics | 3.71B |
| Tango Therapeutics | 3.63B |
| Catalyst Pharmaceuticals | 3.60B |